76.19
+0.86(+1.14%)
Currency In INR
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
191
First IPO Date
October 27, 2016
Name | Title | Pay | Year Born |
Mr. Jitendra Rameshchandra Shah | MD, Chief Executive Officer & Director | 20,000 | 1968 |
Mr. Ritesh Jain | Chief Financial Officer | 0 | N/A |
Mr. Rakesh R. Kalbate | Company Secretary & Compliance Officer | 0 | N/A |
Krebs Biochemicals & Industries Limited manufactures and sells active pharmaceutical ingredients in India. The company develops biotech processes for application in medicine, agriculture, and industry fields. Its products, such as androstenedione, lovastatin, and simvastatin for anti-cholesterol and steroid intermediate applications. The company is also developing various products, including amlodipine, cetirizine, orlistat, serratiopepetidase, telmisartan, and phenylephrine for anti-hypertension, anti-histamine, anti-obesity, anti-inflammatory, and cold and cough applications. In addition, it offers contract manufacturing services for large pharmaceutical and multinational companies. Krebs Biochemicals & Industries Limited was incorporated in 1991 and is headquartered in Hyderabad, India.